Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.07.2011 | Case report

Fludrocortisone

Hypertension in a child: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Wasniewska M, Valenzise M, Aversa T, Mirabelli S, De Luca F, De Luca FL, Lombardo F.Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency. Journal of Endocrinological Investigation 34: 159-161, No. 2, Feb 2011 - Italy Wasniewska M, Valenzise M, Aversa T, Mirabelli S, De Luca F, De Luca FL, Lombardo F.Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency. Journal of Endocrinological Investigation 34: 159-161, No. 2, Feb 2011 - Italy
Metadaten
Titel
Fludrocortisone
Hypertension in a child: case report
Publikationsdatum
01.07.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113580-00067

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Hydrocortisone

Case report

Ceftriaxone